EP3210608 - SOLID PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.08.2022 Database last updated on 24.08.2024 | |
Former | Examination is in progress Status updated on 24.07.2020 | ||
Former | Request for examination was made Status updated on 28.07.2017 | ||
Former | The international publication has been made Status updated on 28.04.2017 | Most recent event Tooltip | 26.08.2022 | Application deemed to be withdrawn | published on 28.09.2022 [2022/39] | Applicant(s) | For all designated states Kyorin Pharmaceutical Co., Ltd. 6, Kanda Surugadai 4-chome Chiyoda-ku Tokyo 101-8311 / JP | [2017/35] | Inventor(s) | 01 /
UCHIDA, Hiroshi c/o WATARASE Research Center KYORIN PHARMACEUTICAL CO. LTD. 1848 Nogi Nogi-machi, Shimotsuga-gun Tochigi 329-0114 / JP | 02 /
HANADA, Masataka c/o WATARASE Research Center KYORIN PHARMACEUTICAL CO. LTD. 1848 Nogi Nogi-machi, Shimotsuga-gun Tochigi 329-0114 / JP | [2017/35] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [2017/35] | Application number, filing date | 15853138.4 | 23.10.2015 | [2017/35] | WO2015JP05344 | Priority number, date | JP20140216515 | 23.10.2014 Original published format: JP 2014216515 | [2017/35] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016063544 | Date: | 28.04.2016 | Language: | JA | [2016/17] | Type: | A1 Application with search report | No.: | EP3210608 | Date: | 30.08.2017 | Language: | EN | [2017/35] | Search report(s) | International search report - published on: | JP | 28.04.2016 | (Supplementary) European search report - dispatched on: | EP | 24.05.2018 | Classification | IPC: | A61K31/4709, A61K9/20, A61P31/04, A61K9/28 | [2018/25] | CPC: |
A61K31/4709 (EP,US);
A61K9/20 (US);
A61K9/2018 (EP,US);
A61K9/2054 (EP,US);
A61K9/2095 (EP,US);
A61K9/2853 (EP,US);
|
Former IPC [2017/35] | A61K31/4709, A61K9/20, A61P31/04 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/35] | Title | German: | FESTE PHARMAZEUTISCHE ZUSAMMENSETZUNG | [2017/35] | English: | SOLID PHARMACEUTICAL COMPOSITION | [2017/35] | French: | COMPOSITION PHARMACEUTIQUE SOLIDE | [2017/35] | Entry into regional phase | 28.04.2017 | Translation filed | 23.05.2017 | National basic fee paid | 23.05.2017 | Search fee paid | 23.05.2017 | Designation fee(s) paid | 23.05.2017 | Examination fee paid | Examination procedure | 28.04.2017 | Date on which the examining division has become responsible | 23.05.2017 | Examination requested [2017/35] | 12.12.2018 | Amendment by applicant (claims and/or description) | 23.07.2020 | Despatch of a communication from the examining division (Time limit: M04) | 19.11.2020 | Reply to a communication from the examining division | 03.05.2022 | Application deemed to be withdrawn, date of legal effect [2022/39] | 24.05.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2022/39] | Fees paid | Renewal fee | 23.10.2017 | Renewal fee patent year 03 | 22.10.2018 | Renewal fee patent year 04 | 23.10.2019 | Renewal fee patent year 05 | 23.10.2020 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.10.2021 | 07   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XD]EP2778159 (KYORIN SEIYAKU KK [JP]) [XD] 1 * abstract * * paragraph [0045] *; | [XP]WO2014174846 (KYORIN SEIYAKU KK [JP]) [XP] 1-8 * abstract * * reference example 4 *; | [E]EP2990038 (KYORIN SEIYAKU KK [JP]) [E] 1-8 * abstract ** reference example 4 * | International search | [X]WO2013069297 (KYORIN SEIYAKU KK [JP]) [X] 1-8 * , particularly, claims 5 to 8, 14 to 16; examples 2, 8 & EP 2778159 A1 claims 5 to 8, 14 to 16; examples 2, 8 & US 2014/0288310 A1 & AU 2012337206 A & CA 2855022 A & CN 103930414 A & KR 10-2014-0098074 A *; | [A]WO2013145749 (KYORIN SEIYAKU KK [JP]) [A] 1-8 * , (Family: none) *; | [A]WO2013145750 (KYORIN SEIYAKU KK [JP]) [A] 1-8 * , (Family: none) *; | [A]WO2006059716 (TAKEDA PHARMACEUTICAL [JP], et al) [A] 1-8 * , & US 2008/0031942 A1 & EP 1825866 A1 *; | [A]JP2013043834 (OHARA YAKUHIN KOGYO KK) [A] 1-8 * , (Family: none) *; | [A]JP2002505290 (Daewoong Pharmaceutical Co., Ltd.) [A] 1-8 * , & WO 1999/044614 A1 & EP 1066040 A & DE 69905452 D & KR 10-0299356 B1 & AU 3277899 A & CA 2322432 A *; | [A]WO2006059716 (TAKEDA PHARMACEUTICAL [JP], et al) [A] 1-8 * , & US 2008/0031942 A1 & EP 1825866 A1 * |